VRCA Stock Analysis: Buy, Sell, or Hold?
VRCA - Verrica Pharmaceuticals Inc. Common Stock
$5.89
0.24 (4.25%)
▲
5d:
-1.83%
30d:
-2.81%
90d:
+31.47%
HOLD
MODERATE Confidence
Analysis Updated: Jun 24, 2026 12:00 AM ET
Earnings: Aug 11, 2026
Get Alerted When VRCA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: VRCA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: VRCA shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: VRCA is currently trading at $5.89, which is considered fair relative to its 30-day fair value range of $5.73 to $6.05.
Technical Outlook: Technically, VRCA is showing sideways momentum. Immediate support is located at $5.62, while resistance sits at $6.80. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: VRCA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.54 (+175.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, VRCA is showing sideways momentum. Immediate support is located at $5.62, while resistance sits at $6.80. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: VRCA has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $15.54 (+175.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.73 -
$6.05
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
55.3%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading 175.1% below Wall St target ($15.54)
Trading Range Analysis
30-Day Trading Range
$5.73 -
$6.05
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.62
Resistance Level
$6.80
Current Trend
Sideways
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.54
Wall Street Target
$15.54
(+175.1%)
Revenue Growth (YoY)
46.1%
Profit Margin
-48.0%
Share & Embed Analysis
Last updated: June 24, 2026 3:07 PM ET
Data refreshes hourly during market hours. Next update: 4:07 PM
Data refreshes hourly during market hours. Next update: 4:07 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VRCA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 53 HOLD |
|
NRIX
Nurix Therapeutics Inc |
STRONG BUY
18 analysts |
$31 | 61 BUY |
|
BNTX
BioNTech SE |
STRONG BUY
21 analysts |
$122 | 58 HOLD |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$128 | 61 BUY |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
14 analysts |
$38 | 58 HOLD |
